Trinity Biotech (TRIB) Interest Coverage Ratio Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) Interest Coverage Ratio Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 100.22% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.28% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -35.05% |
| 10 | Trinity Biotech | 111.52 Mn | 106.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -142.87% |
| Sep 30, 2024 | 34.03% |
| Jun 30, 2024 | 121.99% |
| Mar 31, 2024 | 86.90% |
| Dec 31, 2023 | 39.79% |
| Sep 30, 2023 | 31.08% |
| Jun 30, 2023 | 125.51% |
| Mar 31, 2023 | 46.09% |
| Dec 31, 2022 | -42.97% |
| Sep 30, 2022 | 75.70% |
| Jun 30, 2022 | 30.62% |
| Mar 31, 2022 | 27.93% |
| Dec 31, 2021 | 53.73% |
| Sep 30, 2021 | -20.41% |
| Jun 30, 2021 | 52.49% |
| Mar 31, 2021 | -17.75% |
| Dec 31, 2020 | -120.73% |
| Sep 30, 2020 | -78.80% |
| Jun 30, 2020 | 36.03% |
| Mar 31, 2020 | -7.12% |